Aethlon Medical Secures $4.0M in Highly Dilutive Registered Offering at $0.71
AEMD is trading near its 52-week low of $0.64 (15% above the low) on light trading volume (0.2× avg).
Summary
Aethlon Medical raised approximately $4.0 million in gross proceeds through a registered public offering priced at $0.71 per share, with net proceeds of $3.335 million. This financing is highly material, representing over 200% of the company's current market capitalization, and provides critical liquidity. The offering follows SEC filings yesterday that disclosed the closing of this best-efforts offering. The company's recent 10-K highlighted substantial doubt about its ability to continue as a going concern and a continuous need for dilutive financing, making this capital raise essential but also significantly dilutive for existing shareholders.
At the time of this announcement, AEMD was trading at $0.73 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7M. The 52-week trading range was $0.64 to $27.40. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.